Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Musculoskeletal medicine and orthopaedics indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Steroids are not routine in acute spinal-cord injury

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Cord injury needs systems care, not routine steroid loading

High-dose methylprednisolone does not reverse primary traumatic cord damage and exposes an already vulnerable patient to infection, gastrointestinal bleeding, hyperglycaemia and impaired wound healing.

Action: Do not administer methylprednisolone, nimodipine or naloxone for traumatic cord neuroprotection under NICE guidance; instead protect airway and alignment, prevent hypoxia and hypotension, exclude haemorrhage, obtain CT and urgent MRI for neurology, and involve spinal surgery and a spinal-cord-injury centre early.

Overview

Avoid ineffective and harmful high-dose steroid neuroprotection after traumatic cord injury, distinguish non-traumatic steroid indications, and prioritise oxygenation, perfusion, imaging, decompression and specialist spinal care.

The clinical question is not whether corticosteroids reduce inflammation in theory, but whether a high-dose regimen improves patient-important outcome enough to outweigh harm. NICE concludes that methylprednisolone should not be used for neuroprotection after acute traumatic spinal-cord injury. Nimodipine and naloxone are also not recommended. This makes the bedside decision clear: routine loading, maintenance infusion and transfer solely to complete the course are avoided.

Historical enthusiasm arose from subgroup analyses of trials using very high doses within selected time windows. Subsequent scrutiny found uncertain clinical significance and adverse events, while modern trauma and spinal care emphasises resuscitation, imaging, decompression and prevention of complications. A clock time after injury does not create an indication, and describing therapy as optional can produce inconsistent consent in an emergency where the national recommendation is not to use it.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Musculoskeletal medicine and orthopaedicsOriginal SBA

Routine steroid request

A patient arrives two hours after traumatic cervical cord injury, and a historical protocol suggests high-dose methylprednisolone for neuroprotection. What should the team do?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Musculoskeletal medicine and orthopaedics topics →
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG41 Spinal injury: assessment and initial management
  • BOASt the management of traumatic spinal cord injury
  • NICE NG234 Spinal metastases and metastatic spinal cord compression

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Primary injury occurs at impact through compression, contusion, haemorrhage and axonal disruption. Secondary injury is worsened by hypoxia, hypotension, hypercapnia, fever, oedema and ongoing mechanical compression. The actionable treatments are therefore immediate airway and breathing support, haemorrhage control, organ-appropriate perfusion, temperature management, safe alignment, CT and MRI and timely specialist surgical decision-making.

Steroid harm is particularly relevant in polytrauma. Hyperglycaemia impairs immune and wound function; immunosuppression increases respiratory and surgical infection; gastrointestinal bleeding adds haemodynamic risk; delirium and sleep disturbance complicate neurological assessment; and proximal myopathy hinders rehabilitation. These harms can follow even before a neurological benefit could be judged, and they interact with open fractures, abdominal surgery and critical-care devices.

A prior dose should prompt clarification rather than panic. Record the exact drug, dose, route, start time and indication, tell the spinal and critical-care teams and do not continue a non-indicated course automatically. Monitor glucose, infection, gastrointestinal bleeding, electrolytes, mental state and wound healing according to exposure and condition. A single dose does not remove the need for standard CT, MRI, decompression review or neurological classification.

Not all cord compression is traumatic. NICE metastatic spinal-cord-compression guidance uses dexamethasone in people with neurological symptoms or signs of malignant compression. Inflammatory myelitis may receive specialist immune therapy. Adrenal crisis requires hydrocortisone. These diagnoses have distinct mechanisms, imaging and regimens. Applying the trauma prohibition to them—or importing their steroid use into traumatic injury—are both category errors.

Communication prevents reintroduction. State in the trauma plan that high-dose steroid neuroprotection is not indicated, cite current NICE guidance and hand over the effective priorities: neurological level and sacral sparing, respiratory mechanics, perfusion and bleeding status, CT and MRI findings, operative timing, pressure care, VTE prevention and spinal-centre liaison. Audit steroid administration as a medication-safety event when it occurs outside a justified alternative diagnosis.

Key points

  • NICE says not to use methylprednisolone, nimodipine or naloxone in the acute stage after traumatic spinal-cord injury for neuroprotection.
  • Do not start a historical high-dose methylprednisolone regimen because presentation is within an alleged treatment window; timing does not create a NICE indication.
  • Run ABCDE with spinal protection, support a weak high-cervical airway and ventilation early and prevent even brief hypoxaemia.
  • Exclude and control haemorrhage before diagnosing neurogenic shock, then use specialist perfusion support rather than steroid bolus.
  • Obtain CT for fracture and alignment and MRI after CT when neurological abnormality could be attributable to cord, disc, ligament or epidural injury.
  • Discuss decompression and stabilisation urgently with spinal surgery and contact a spinal-cord-injury centre early for respiratory, skin, bladder, bowel and rehabilitation care.
  • If steroids were already given, stop further non-indicated dosing, document product, dose and time and monitor glucose, infection, gastrointestinal and wound complications.
  • Separate traumatic cord injury from malignant compression, inflammatory myelitis and adrenal crisis, where steroids may be indicated through a different evidence-based pathway.

Aetiology

01

Traumatic compression or contusion

Fracture, dislocation, disc, ligament or epidural injury mechanically damages cord and produces the clinical scenario where outdated steroid practice may be suggested.

02

Historical protocol carryover

Earlier trials led some services to use prolonged high-dose methylprednisolone, despite uncertain benefit, restrictive timing analyses and important adverse events.

03

Diagnostic confusion

Malignant compression, inflammatory myelopathy and adrenal insufficiency are steroid-responsive contexts that can be mistakenly conflated with acute traumatic cord injury.

Pathophysiology

  1. 1
    Irreversible primary injury

    Mechanical axonal disruption, haemorrhage and cellular destruction occur at impact and cannot be repaired by a corticosteroid infusion.

  2. 2
    Secondary injury cascade

    Oedema, microvascular failure, excitotoxicity, inflammation, hypoxia and hypotension extend damage, but systemic steroid immunosuppression has not shown a reliable net clinical benefit.

  3. 3
    Steroid toxicity

    Large doses cause hyperglycaemia, infection, gastrointestinal injury, delirium, myopathy and poor tissue healing, compounding trauma and surgical risk.

  4. 4
    Effective physiological protection

    Oxygenation, ventilation, haemorrhage control, appropriate perfusion, temperature management and timely decompression directly address preventable secondary insults.

Clinical features and red flags

Traumatic cord syndrome

Immediate motor, sensory or sacral deficit after a clear injury mechanism belongs to the acute trauma pathway where routine steroid neuroprotection is not advised.

Mechanical compression

CT fracture, translation or MRI disc, haematoma and cord compression requires urgent surgical review rather than reliance on pharmacological swelling reduction.

Secondary physiological insult

Hypoxia, hypotension, hypercapnia, fever and falling respiratory capacity identify treatable threats with more direct relevance to cord survival.

Steroid adverse effect

New severe hyperglycaemia, infection, melaena, agitation or wound deterioration after dosing requires review and treatment of medication harm.

Red flags requiring action

  • New weakness, sensory level, sacral change, respiratory muscle weakness or sphincter dysfunction after trauma requires emergency cord assessment and must not be delayed while debating steroid administration.
  • Hypotension, hypoxaemia, rising carbon dioxide, hypothermia and ongoing compression are modifiable causes of secondary injury that demand immediate treatment.
  • A proposed steroid indication may be non-traumatic—such as malignant cord compression, inflammatory myelitis or adrenal crisis—and requires its own diagnosis and regimen rather than transfer of trauma guidance.

Investigations

  1. 01
    First-line trauma and neurological assessmentFirst stepFirst line
    Why
    Confirm mechanism, level, completeness and immediate physiological threats.
    Interpretation and limitations
    Document ISNCSCI motor, sensory and sacral findings with respiratory and haemodynamic status; do not delay this for an empirical medicine trial.
  2. 02
    Preferred CT spinePreferred
    Why
    Define bony injury, displacement and canal fragments.
    Interpretation and limitations
    Use complete adult cross-sectional imaging where indicated and review the whole spine in high-risk patterns; CT does not replace MRI for cord neurology.
  3. 03
    MRI after CT
    Why
    Identify cord oedema, haemorrhage, disc, ligament and epidural compression.
    Interpretation and limitations
    Obtain urgently for attributable neurological abnormality so decompression and stabilisation are based on anatomy rather than a steroid response.
  4. 04
    Blood gas and perfusion assessment
    Why
    Detect hypoxia, hypercapnia, shock and reversible secondary injury.
    Interpretation and limitations
    Trend carbon dioxide, lactate or base deficit, temperature and response to haemorrhage treatment and respiratory support.
  5. 05
    Glucose and infection monitoring after exposure
    Why
    Detect common high-dose corticosteroid harm.
    Interpretation and limitations
    Measure glucose and review temperature, WBC, cultures and wounds according to clinical context; do not screen indiscriminately without interpreting trauma inflammation.
  6. 06
    Alternative-diagnosis work-up
    Why
    Identify malignant, inflammatory, infectious or endocrine steroid indications.
    Interpretation and limitations
    Use history, MRI pattern, cancer status, inflammatory and endocrine testing with the relevant specialty instead of assuming every cord syndrome is traumatic.

Differential diagnosis

01

Malignant spinal-cord compression

Cancer-related pain and progressive neurology may need dexamethasone under the oncology pathway, urgent MRI and definitive radiotherapy or surgery.

02

Inflammatory myelitis

Subacute bilateral neurological dysfunction without a traumatic mechanism requires neurological investigation and may receive specialist corticosteroid or immune treatment.

03

Cauda equina compression

Disc prolapse, tumour, abscess or haematoma can cause saddle and sphincter symptoms and needs emergency MRI and decompression, with antimicrobials or steroids only by cause.

04

Adrenal crisis

Shock in a steroid-dependent patient needs stress-dose hydrocortisone, but this treats endocrine failure rather than traumatic spinal neuroprotection.

Additional chapter-specific clues

Malignant alternative

Known cancer, progressive night pain and subacute neurology may indicate metastatic compression, where dexamethasone and urgent oncological imaging follow a separate NICE pathway.

Inflammatory alternative

Subacute neurological dysfunction, systemic inflammation or non-compressive MRI lesions without trauma requires neurology assessment before immune therapy.

Management

01ImmediateUse effective neuroprotectionFirst stepA patient has neurological signs after acute spinal trauma.+
  1. 1Run ABCDE with safe spinal alignment, support ventilation, control haemorrhage and prevent hypoxia, hypotension and hypothermia.
  2. 2Document motor, sensory and sacral findings and arrange complete CT and MRI after CT for attributable cord abnormality.
  3. 3Contact spinal surgery and a spinal-cord-injury centre early and plan decompression, stabilisation and transfer according to anatomy and physiology.
  4. 4Record that methylprednisolone, nimodipine and naloxone are not indicated for traumatic cord neuroprotection under NICE guidance.
02ExposureManage an already administered steroidHigh-dose corticosteroid was given before review or during transfer.+
  1. 1Confirm drug, dose, route, timing, intended duration and the clinical rationale and communicate exposure to pharmacy and receiving teams.
  2. 2AlternativeStop automatic continuation when no alternative indication exists, without delaying spinal imaging or surgery.
  3. 3Monitor glucose, gastrointestinal bleeding, infection, mental state, electrolytes and wound healing according to dose and patient vulnerability.
  4. 4Report and review inappropriate administration through medication governance so historical protocols are removed from pathways and packs.
03Different diagnosisUse steroids only for a separate indicationClinical course or imaging is not consistent with acute traumatic cord injury.+
  1. 1Consider malignant compression, inflammatory myelitis, spinal infection, adrenal crisis and other neurological or endocrine causes.
  2. 2Obtain the correct urgent imaging and specialist input before transferring a regimen from one disease to another.
  3. 3AlternativeUse the named national or specialty protocol with exact drug, route, dose, duration and safety monitoring for the confirmed alternative.
  4. 4Continue mechanical, respiratory, bladder, bowel, skin and VTE care appropriate to the patient's neurological impairment.
Key medicines and prescribing safety1 treatment · regimens, roles and cautions+
There is no recommended routine neuroprotective role in acute traumatic spinal-cord injury; effective care targets oxygenation, perfusion and mechanical compression.

Methylprednisolone for traumatic cord neuroprotection

Do not administer a high-dose methylprednisolone bolus or infusion for neuroprotection in the acute stage of traumatic spinal-cord injury; NICE recommends against this treatment.

High-dose exposure can cause severe infection, hyperglycaemia, gastrointestinal bleeding, delirium, myopathy and impaired wound healing; a distinct malignant, inflammatory or endocrine indication needs its own specialist regimen.

Complications

01

Serious infection

Immunosuppression increases pneumonia, wound and line infection in patients already exposed to ventilation, surgery and prolonged admission.

02

Gastrointestinal bleeding

Physiological stress, anticoagulation and high-dose corticosteroid exposure combine to increase clinically important ulceration and gastrointestinal haemorrhage.

03

Hyperglycaemia and delirium

Marked glucose elevation impairs immunity and wound healing, while mood, sleep and cognitive effects complicate neurological care.

04

Delayed definitive care

Focusing on an unhelpful infusion can postpone airway support, MRI, transfer, decompression and haemorrhage control that determine outcome.

Monitoring and follow-up

  • Trend respiratory mechanics, carbon dioxide, pressure, perfusion, temperature and neurological level rather than using steroid administration as a treatment endpoint.
  • Track CT, MRI, spinal-surgeon discussion and time to decompression or stabilisation where indicated.
  • If exposed, monitor glucose, infection, gastrointestinal bleeding, mental state, wound and muscle function and document when dosing stopped.
  • Repeat motor, sensory and sacral classification after resuscitation and surgery to detect true neurological change.
  • Audit non-indicated steroid use, remove legacy order sets and provide feedback across referring and receiving services.

Special situations

A historical window is not an indication

Being seen within several hours of injury does not override current NICE advice against routine methylprednisolone neuroprotection.

Physiology is active neuroprotection

Preventing hypoxia and hypotension and relieving relevant compression address mechanisms that clearly worsen secondary cord damage.

One dose still needs documentation

Exact exposure informs glucose, infection, operative and handover plans even when the course is stopped.

Cause determines steroid use

Malignant compression and inflammatory myelitis are not exceptions within trauma; they are different diagnoses with different pathways.

Order sets preserve old practice

Removing outdated pre-printed regimens is often more effective than relying on clinicians to challenge them during emergencies.

Common pitfalls

  1. 01

    Starting high-dose methylprednisolone because the injury occurred within a historical trial window.

  2. 02

    Delaying airway support, MRI or spinal transfer while arranging a steroid infusion.

  3. 03

    Assuming a steroid response can diagnose or exclude mechanical cord compression.

  4. 04

    Continuing an initiated course without checking the indication and current NICE recommendation.

  5. 05

    Ignoring glucose, infection, gastrointestinal and wound harm after a dose has been given.

  6. 06

    Withholding indicated dexamethasone or hydrocortisone from a separate malignant or endocrine emergency by misapplying trauma guidance.